Abstract
Molecular biology has been integrated into ophthalmology remarkably well because it promotes an accurate diagnosis and the development of front-line treatments. In the past ten years, next generation sequencing, including variant technologies, has been developed and clinically adopted because of its cost-efficiency and high throughput. In this context, we mainly describe its properties, strengths and weaknesses, with an emphasis on and a perspective of its usefulness in inherited eye disorders. Key words: Molecular ophthalmology; Next generation sequencing; Genetic diagnosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
